Search for: "3M Co."
Results 341 - 360
of 381
Sorted by Relevance
|
Sort by Date
3 Aug 2022, 9:16 am
In a letter addressed to Treasury Secretary Janet Yellen, the Alliance for Competitive taxation—a group whose members include the likes of Coca Cola, Disney, and 3M—urged against the BBBA’s adoption of Pillar Two. [read post]
15 Oct 2020, 1:32 pm
” These twenty-somethings claim to have “co-invented” and patented Loop’s technology that no other company was able to do. [read post]
11 Feb 2024, 3:03 pm
In 2023, the drinking water cases resulted in very large proposed settlements. 3M reached a tentative settlement to pay approximately $12.5 billion, and DuPont de Nemours, Inc., Chemours Company, and Corteva, Inc. [read post]
5 Aug 2008, 3:36 pm
The unit of McGraw-Hill Cos. is the largest bond-rating firm by revenue. [read post]
4 Nov 2015, 5:16 am
This report was co-written by MuckRock Editor JPat Brown. [read post]
15 Mar 2008, 7:00 am
India: Gene silencing: (Spicy IP), India: US Patent reform implications for Indian Pharma: (Spicy IP), India: Generic pharmaceutical industry in the spotlight: (International Law Office), India: Supreme Court refuses to stay a Gujarat High Court decision restraining Ranbaxy from airing its controversial ads directed against Paras Pharma's 'Moov' brand: (Spicy IP),India: Patents on ARV drugs could increase costs: (Generic Pharmaceuticals & IP),US: Survey shows most Americans… [read post]
20 May 2020, 1:58 pm
For an analysis under US law, see Pledge Co-founder and Creative Commons GC Diane Peters’ whitepaper. [read post]
20 Jan 2021, 9:02 pm
The award consists of a plaque and a $2,500 honorarium.Sponsored by: 3M Food Safety Ewen C.D. [read post]
1 Jan 2019, 5:10 pm
The Department has investigated efforts by drug manufacturers to facilitate increases in drug prices by funding the co-payments of Medicare patients. [read post]
28 Mar 2008, 6:00 am
You can separately subscribe to the IP Thinktank Global week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included:Forbes interview with M Meurer (co author of ‘Patent Failure’): (Patent Prospector), (IPBiz), (IPBiz), (IPBiz), (IAM), (Technological Innovation and Intellectual Property), (Patent Prospector),Rambus – Rambus stock soars following jury’s dismissal of antitrust and fraud charges from Hynix, Micron, and Nanya… [read post]
21 Apr 2011, 1:36 pm
The court found all of these theories “essentially nonexistent” against a non-manufacturer, and that there was no evidence that the branded defendant was somehow an licensee, agent, or co-conspirator with the generic manufacturer. [read post]
9 Sep 2020, 12:05 pm
Co. v. [read post]
2 Sep 2010, 8:35 am
RE 39,947 owned by Johnson Research & Development Co., Inc. and entitled TOY WATER GUN. [read post]
23 Dec 2007, 8:00 pm
You can separately subscribe to the IP Thinktank Global week in Review at [feeds.feedburner.com]GlobalEvents in Bali heap further pressure on all IP owners: (IAM),Velcro defies generic claim in domain name battle: (OUT-LAW),ICANN forms group to hasten non-English domain names: (IP Justice)WTO members continue debate on geographical indications register: (Intellectual Property Watch),Creative Commons launches CCo and CC programs: (World IP Day),Green IP Strategy - risks… [read post]
1 Mar 2010, 7:11 pm
Blistex, Ciba, Pfizer, 3M, Edgecraft, Darex, Cisco, Bunn-O-Matic, Oreck, Novartis, Merck, etc. [read post]
14 Jun 2011, 7:01 am
The Class Actions Post-Concepcion: A Defining Moment in American Jurisprudence Whatever happened to state’s rights, Justice Scalia? [read post]
1 Mar 2010, 7:11 pm
Blistex, Ciba, Pfizer, 3M, Edgecraft, Darex, Cisco, Bunn-O-Matic, Oreck, Novartis, Merck, etc. [read post]
13 Oct 2008, 12:12 pm
Here is IP Think Tank’s weekly selection of top intellectual property news breaking in the blogosphere and internet. [read post]
19 Feb 2018, 6:29 am
Inside and outside counsel need only to both plug in the MMM (sadly, my branding team informs that M&M, 3M, and M3 all seem to be taken). [read post]
20 May 2012, 1:11 pm
On the face of it, Plavix's patent expiry may have arguably paved the way for Eli Lilly & Co's and AstraZeneca's own blood-thinning drugs, Effient and Brilinta respectively, to gain more market share but the expiry of the patent does not mean that increasing the market share of their competitor drugs will be easy. [read post]
